Siemens Healthineers' medical technology impacts 240,000+ patients worldwide per hour

Healthcare has evolved over the years along with the types of ailments affecting people. The role of procedure assisting devices and decision support tools have made a significant impact in the field of medicine, making healthcare safer and less expensive for patients. The Economist Intelligence Unit (EIU) has continuously urged healthcare providers to invest in ICT infrastructure and apps^7;p3. The Journal of Public Health Research has further published that technology drives healthcare more than any other force¹. These are also known to free up human resources (surgeons, doctors, clinicians, nurses, etc.) for more pressing responsibilities^2,3.

Siemens Healthineers is the parent body of multiple medical technology companies engaged over three functional divisions – imaging, diagnostics, and advanced therapies⁴. Its medical imaging market share is the largest in the world at over 23%¹³. It has its presence in more than 70 countries and owns over 18,500 patents, patent applications, and utility models⁵. The company collaborates with researchers, partners, caregivers, and global institutions – including 90% of the world’s leading hospitals⁶. 75% of all global clinical decisions are said to be influenced by solutions from Siemens Healthineers⁶. Moreover, 240,000+ patients worldwide are impacted by their technologies every hour⁶.

Siemens has laid multiple medical technology milestones over the course of 170 years of existence⁸. From the earliest X-ray imaging equipment in 1896 to the latest immunodiagnostics system from 2016, its products and solutions have been at the forefront of innovation and trendsetting^9,10. More lately, over the last 20 years, its AI-based portfolio has enhanced clinical decision-making and aided the research and development of other incremental medical technologies^11,12.

Modern, innovative digital health solutions from Siemens have truly improved global healthcare provision.